Real-world safety study of desidustat for kidney anemia
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tracks the real-world safety of desidustat in adults with anemia caused by chronic kidney disease (CKD). It’s meant to see whether the medicine is safe when used in everyday care, not just in tightly controlled settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have a current diagnosis of CKD-related anemia.
- Your hemoglobin level is between 7.0 and 11.0 g/dL (inclusive) before joining.
- You can understand the study and sign informed consent.
- You do not have a significant lack of folate or vitamin B12.
- If you’re on hemodialysis: you get dialysis at least 2 times per week for 12+ weeks and have a working access line (fistula, graft, or catheter).
- You haven’t had a red blood cell transfusion in the last 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called Efepoetin Alfa to treat anemia in people with chronic kidney disease who are on dialysis. The goal is to see if it can safely raise red blood cell levels and reduce the need for other anemia treatments.
This study tests a daily pill that helps people with chronic kidney disease and anemia make more red blood cells, which may reduce the need for other anemia treatments. It is for patients who are not on dialysis and do not plan to start dialysis or have a kidney transplant within the next six months.
This study tests whether a pill called roxadustat can help improve kidney oxygen levels in people with diabetes-related kidney disease and anemia. It may help boost your red blood cells and improve how your kidneys work.
This study is collecting information from people with chronic kidney disease and anemia who are taking a medication called daprodustat. The goal is to learn more about how well it works and how it affects patients in real life.
This study tests an experimental medicine for anemia in people with kidney disease who are on dialysis. It aims to see if it can help raise blood counts safely compared to standard treatments.
This study tests a new pill, vadadustat, for people on dialysis who have anemia. It looks at whether switching from the current treatment (Epogen) to this pill is safe and works well.
Hear when a new Anemia of Chronic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.